Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure
Year: 2026
Type: article
Abstract: This secondary analysis of the FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure) randomized clinical trial investigates the prevalence of undiagnosed chronic kidney disease in high-risk individuals with heart failure and its association with cardiovascular outcomes.
Source: JAMA Cardiology
Authors: John W. Ostrominski, Finnian R. Mc Causland, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Flaviana Amarante, Meike Brinker, Patrick Schloemer, Katja Rohwedder, John J. V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
Institutions: Brigham and Women's Hospital, Harvard University, University of Glasgow, National University of Singapore, National Heart Centre Singapore, Ospedale Papa Giovanni XXIII, University of Milano-Bicocca, Northwestern University, University Medical Center Groningen, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine, University of Michigan, Michigan Medicine, Bayer (Germany)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: Bayer, Brigham and Women's Hospital
OpenAlex ID: W7214122162